EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Issues with RNF43 antibodies to reliably detect intracellular location

Shanshan Li, Ruyi Zhang, Marla Lavrijsen, Thierry P P van den Bosch, Maikel P Peppelenbosch, Ron Smits

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0283894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Shanshan Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: beta Catenin, DNA-Binding Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNF43 is an important negative regulator of β-catenin signaling by removing Wnt-receptors from the membrane. It is often mutated in cancers, leading to aberrant Wnt-dependent nuclear translocation of β-catenin. RNF43 has also been suggested to regulate β-catenin signaling directly within the nucleus, among other proposed nuclear functions. Given the importance of RNF43 in regulating Wnt/β-catenin signaling and its potential therapeutic relevance, a proper understanding of RNF43 biology is required. However, the presumed nuclear location is mainly based on available antibodies. These same antibodies have also been used extensively for immunoblotting or immunohistochemical purposes. However, a proper evaluation of their quality to reliably detect endogenous RNF43 has not been performed. Here, using genome editing we have generated a cell line that entirely misses RNF43 exons 8 and 9, encoding the epitopes of commonly used RNF43 antibodies. Using this clone in addition to various other cell line tools, we show that four RNF43 antibodies only yield non-specific signals when applied in immunoblotting, immunofluorescence and immunohistochemical experiments. In other words, they cannot reliably detect endogenous RNF43. Our results suggest that the nuclear staining patterns are an antibody artifact and that RNF43 is unlikely to localize within the nucleus. More generally, reports using RNF43 antibodies should be interpreted with caution, at least for the RNF43 protein aspects described in these papers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta CateninDNA-Binding ProteinsUbiquitin-Protein LigasesOncogene ProteinsWnt Signaling Pathway

Substanzen

beta CateninDNA-Binding ProteinsUbiquitin-Protein LigasesOncogene Proteins

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Förderung

  • China Scholarship Council

Zitieren

APA

Li, S., Zhang, R., Lavrijsen, M., van den Bosch, T. P. P., Peppelenbosch, M. P., & Smits, R. (2023). Issues with RNF43 antibodies to reliably detect intracellular location. PLOS ONE. https://doi.org/10.1371/journal.pone.0283894

Vancouver

Li S, Zhang R, Lavrijsen M, van den Bosch TPP, Peppelenbosch MP, Smits R. Issues with RNF43 antibodies to reliably detect intracellular location. PLOS ONE. 2023. doi:10.1371/journal.pone.0283894

BibTeX
@article{Li2023,
  author = {Li, Shanshan and Zhang, Ruyi and Lavrijsen, Marla and van den Bosch, Thierry P P and Peppelenbosch, Maikel P and Smits, Ron},
  title = {Issues with RNF43 antibodies to reliably detect intracellular location},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0283894}
}
Kostenlos starten →